J. McCormack

发表

Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides.

J. Roth, V. Marquez, J. Driscoll, 1986, Journal of medicinal chemistry.

Efficacy and toxicity of 4-(2-sulfonatoethylthio)-cyclophosphamide cyclohexylamine salt (ASTA Z 7557, INN mafosfamide) after intraperitoneal administration to mice

John D. Roberts, R. Newman, M. Hacker, 2004, Investigational New Drugs.

Clinical pharmacology and metabolism of trimetrexate.

J. Bertino, W. Tong, M. Fanucchi, 1988, Seminars in oncology.

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.

M. Hollingshead, D. Clanton, William Q. Rice, 1998, Journal of medicinal chemistry.

Oxidation of selected pteridine derivatives by mamalian liver xanthine oxidase and aldehyde oxidase.

J. McCormack, J. Sabean, C. Hodnett, 1976, Journal of pharmaceutical sciences.

Interaction of warfarin and nonsystemic gastrointestinal drugs

D. M. Benjamin, D. Robinson, J. McCormack, 1971, Clinical pharmacology and therapeutics.

A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections

W. Tong, J. Jolivet, E. Eisenhauer, 1987, Cancer Chemotherapy and Pharmacology.

Diet modulates the toxicity of cancer chemotherapy in rats.

R. Branda, T. Trainer, J. McCormack, 2002, The Journal of laboratory and clinical medicine.

Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.

R. Newman, I. Krakoff, J. Griffin, 1982, Cancer treatment reports.

Chapter 5 Pharmacology of Antitumor Bisindole Alkaloids from Catharanthus

J. McCormack, 1990 .

Oxidation of pteridine derivatives in mice.

J. Knipe, J. McCormack, 1977, Biochemical pharmacology.

Phosphofructokinase activity in particulate-free extracts of Trypanosoma (Trypanozoon) rhodesiense.

J. McCormack, J. Jaffe, E. Meymarian, 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.

Activity of 2,4-Diaminoquinazoline Compounds against Candida species

J. McCormack, R. Castaldo, D. Gump, 1979, Antimicrobial Agents and Chemotherapy.

Presence and properties of dihydrofolate reductases within the genus Trypanosoma.

W. Gutteridge, J. McCormack, J. Jaffe, 1968, British journal of pharmacology.

Vitamin E but not St. John's wort mitigates leukopenia caused by cancer chemotherapy in rats.

R. Branda, J. McCormack, Z. Yildirim, 2006, Translational research : the journal of laboratory and clinical medicine.

A Revised Scheme for the Evaluation of Automatic Instruments for Use in Clinical Chemistry

P M Broughton, D. W. Neill, A H Gowenlock, 1974, Annals of clinical biochemistry.

Oxidation of quinazoline and quinoxaline by xanthine oxidase and aldehyde oxidase

J. McCormack, C. Hodnett, B. A. Allen, 1978 .

Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds.

J. McCormack, W. Richter, J. J. Mccormack, 1974, Journal of medicinal chemistry.

Comparative properties of schistosomal and filarial dihydrofolate reductases.

J. McCormack, J. Jaffe, E. Meymarian, 1972, Biochemical pharmacology.

2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.

J. J. Heusner, S. Queener, A. Rosowsky, 1993, Journal of medicinal chemistry.

Dihydrofolate reductase inhibitors as potential drugs

John J. McCormack, J. McCormack, 1981, Medicinal research reviews.

Immunosuppressive properties of chloroquinoxaline sulfonamide.

R. Branda, J. McCormack, A. L. Moore, 1989, Biochemical pharmacology.

Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells.

R. Branda, J. McCormack, C. Perlmutter, 1988, Biochemical pharmacology.

Synthesis and antitumor activity of platinum complexes containing neutral and protonated amino-olefin ligands

A. Khokhar, M. Hacker, J. McCormack, 1982 .

Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones.

M. Hacker, A. P. Krapcho, J. McCormack, 1985, Journal of medicinal chemistry.

Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.

D. Brown, A. Khokhar, M. Hacker, 1986, Cancer Research.

New biologically active cyclophosphazene derivatives

R. Newman, J. A. MacKay, M. Hacker, 1982 .

Xanthine oxidase-mediated oxidation of epinephrine.

J. McCormack, D. Valerino, J. J. Mccormack, 1971, Biochemical pharmacology.

Comparative activity and properties of lactate dehydrogenase, xanthine dehydrogenase, and dihydrofolate reductase in normal and Brugia pagangi-infected Aedes aegypti.

J. McCormack, J. Jaffe, E. Meymarian, 1977, The Journal of parasitology.

Dihydrofolate reductases within the genus Trypanosoma.

W. Gutteridge, J. McCormack, J. Jaffe, 1969, Experimental parasitology.

Amplification of antibody production by phosphorothioate oligodeoxynucleotides.

R. Branda, G. Zon, A. Lafayette, 1996, The Journal of laboratory and clinical medicine.

Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.

R. Branda, G. Zon, J. McCormack, 1993, Biochemical pharmacology.

Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes

A. Khokhar, M. Hacker, J. McCormack, 2004, Cancer Chemotherapy and Pharmacology.

Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.

D. Brown, A. Khokhar, M. Hacker, 1985, Cancer research.

Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine.

J. McCormack, J. Bigelow, L. Mathews, 2002, Biochemical pharmacology.

Studies of the oxidation of some aminopteridines by xanthine oxidase.

J. McCormack, D. Valerino, J. J. Mccormack, 1969, Biochimica et biophysica acta.

A phase I study of trimetrexate

W. Tong, J. Stewart, J. McCormack, 1985 .

Blockage of fertilization in Rana pipiens by trypsin inhibitors.

J. P. Davanzo, J. McCormack, F. Greenslade, 1973, Biology of reproduction.

Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.

M. Hacker, D. Phinney, A. P. Krapcho, 1986, Journal of medicinal chemistry.

Clinical and clinical pharmacologic studies of mitoxantrone.

J. Stewart, I. Krakoff, J. McCormack, 1982, Cancer treatment reports.

Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase.

D. R. Haines, V. Marquez, J. McCormack, 1986, Journal of medicinal chemistry.

Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring size.

R. Fuller, V. Marquez, J. Driscoll, 1981, Journal of medicinal chemistry.

Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds.

V. Marquez, J. Driscoll, D. Vistica, 1980, Biochemical pharmacology.

Nucleophilic Displacement Reactions of 2-Amino-4-alkylthiopteridines1-3

H. Mautner, J. McCormack, J. J. Mccormack, 1964 .

Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation.

L. Haugh, R. Newman, J. Stewart, 1987, Cancer treatment reports.

Enzymatic assays for 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, a promising new "nonclassical" antifolate.

J. J. Heusner, J. McCormack, 1981, Journal of Pharmacy and Science.

Inhibition of dihydrofolate reductases by derivatives of 2,4-diaminopyrroloquinazoline.

J. McCormack, B. Hillcoat, B. A. Allen, 1979, Biochemical pharmacology.

The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids.

W. Gutteridge, J. McCormack, J. Jaffe, 1969, Biochimica et biophysica acta.

Presence and properties of dihydrofolate reductases within the genus Crithidia.

W. Gutteridge, J. McCormack, J. Jaffe, 1969, Biochimica et biophysica acta.

A Rapid and Sensitive Method for Determination of Trimetrexate from Biological Fluids

W. Tong, J. McCormack, J. Hartshorn, 1985 .

Further pharmacological studies of 2,4-diamino-5-methyl-6-[(3,4,5- -trimethoxyanilino)methyl]quinazoline (nsc 249008; tmq). Abstr.

M. Hacker, J. J. Heusner, J. McCormack, 1981 .

CYCLIC UREA NUCLEOSIDES. CYTIDINE DEAMINASE ACTIVITY AS A FUNCTION OF AGLYCON RING SIZE

R. Fuller, V. Marquez, J. Driscoll, 1981 .

Synthesis of 1,3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase.

V. Marquez, J. Driscoll, J. Kelley, 1980, Journal of medicinal chemistry.

Inhibition of Cytidine Deaminase by Derivatives of 1-(β-D-Ribofuranosyl)-Dihydropyrimidin-2-One (Zebularine)

V. Marquez, J. Barchi, A. Haces, 1992 .

Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine).

L. Jeong, V. Marquez, D. Cooney, 1998, Journal of medicinal chemistry.

Effects of folate deficiency on the metastatic potential of murine melanoma cells.

R. Branda, S. Robison, J. McCormack, 1988, Cancer research.

Water-soluble / V-substituted Iminodiacetato ( l , 2-diaminocyclohexane )-platinum ( II ) Complexes as Potential Antitumor Agents 1

D. Brown, A. Khokhar, M. Hacker, 2006 .

Water-soluble Antitumor Drugs1

A. Khokhar, M. Hacker, I. Krakoff, 1985 .

Beetle Diversity Across Micro-habitats on Lizard Island Group (Great Barrier Reef, Australia).

J. McCormack, Darko D. Cotoras, 2021, Zoological studies.

Inhibition of lymphocyte nucleic acid metabolism and antibody production by trimetrexate.

R. Branda, J. McCormack, A. L. Moore, 1987, Biochemical pharmacology.

A Sensitive High Pressure Liquid Chromatographic Technique by Which to Measure Didemnin B in Biological Fluids

W. Tong, J. Stewart, J. McCormack, 1986 .

D. W. Neill, P. M. G. Broughton, R D Jennings, 1980 .

Investigation of the Validity of Temperature Correction Factors for Serum Aspartate and Alanine Transaminases

J. H. Wilkinson, S. Rosalki, J. Wilkinson, 1975, Annals of clinical biochemistry.

The synthesis and antitumor properties of a series of water soluble carboxylato-( 1,2-diaminocyclohexane) platinum(II) complexes

A. Khokhar, M. Hacker, I. Krakoff, 1985 .

Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule.

L. Haugh, L. Whitfield, W. Tong, 1988, Cancer research.

Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.

W. Tong, J. McCormack, L. Webster, 1985, Cancer letters.

Disposition of the non-classical folate antagonist 2,4-diamino-5-methyl-6-(3,4,5-trimethoxyanilino) methylquinazoline (TMQ; trimetrexate) in mice

W. Tong, J. J. Heusner, J. McCormack, 1985 .

Effect of trimethoprim, paracetamol and cimetidine on trimetrexate metabolism by rat perfused isolated livers

W. Tong, L. Webster, J. McCormack, 1987, The Journal of pharmacy and pharmacology.

Influence of hypoxia on the metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.

J. McCormack, L. Webster, 1986, Biochemical Pharmacology.

Pteridines. 41. Synthesis and dihydrofolate reductase inhibitory activity of some cycloalka[g]pteridines.

R. Kobylecki, J. McCormack, E. Taylor, 1977, Journal of medicinal chemistry.